US › Healthcare

Medline Inc. Class A Common Stock (MDLN)

US · Healthcare · Medical Instruments & Supplies

$42.04+3.88%
Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue
$7.35B
Revenue YoY
+10.7%
Net profit
$129.0M
Profit YoY
-59.9%
EPS
$0.33
EPS estimate
$0.29
Net margin
1.8%

EPS came in at 0.33 against a street estimate of 0.29 — a beat of 13.8%.

Key statistics

Market cap
$69.99B
P/E
34.5
Forward P/E
26.6
P/B
2.95
Book value
$13.32
EPS (TTM)
$1.14
52-week high
$50.88
52-week low
$32.81
50-day MA
$37.97
200-day MA
$41.91

Analyst view

with an average price target of $50.65.

Shareholding

Insiders
0.21%
Institutions
101.69%

Largest institutional holders

FundStake
The Carlyle Group Inc22.12%
H&F Corporate Investors X, Ltd.10.23%
FMR Inc4.32%
Capital Research Global Investors2.74%
Amvescap Plc.2.48%
BlackRock Inc2.00%
Egerton Capital LLP1.95%
Morgan Stanley - Brokerage Accounts1.86%

Recent filings & reports

DocumentDate
Board / officer change · Q3 20262026-07-09
Shareholder vote results · Q2 20262026-06-12
Material agreement · Q2 20262026-06-02
Quarterly report · Q1 20262026-05-06
Results announced · Q2 20262026-05-06
Proxy statement · Q2 20262026-04-23
Annual report FY20252026-02-25

Readable in the app.

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Medline Inc. Class A Common Stock — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences Inc

Data updated 2026-08-05.